Amunix Pharmaceuticals has appointed Maninder Hora to serve as chief technical operations officer, the same position he held at Nektar Therapeutics (NASDAQ: NKTR). Mountain View, CA-based Amunix is developing a type of cancer drug called a T cell engager using technology that the company says overcomes the limitations of these immunotherapies.
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Brex
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences
